✦ LIBER ✦

Safety and immunogenicity profile of a recombinant outer-surface protein a Lyme disease vaccine: Clinical trial of a 3-dose schedule at 0, 1, and 2 months

✍ Scribed by Robert T. Schoen; Vijay K. Sikand; Michael C. Caldwell; C. Van Hoecke; Marc Gillet; Charles Buscarino; Dennis L. Parenti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, nonrandomized, single-cen

✍ Robert T Schoen; Terry Deshefy-Longhi; Christian Van-Hoecke; Charles Buscarino; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 816 KB

Safety and immunogenicity of recombinant

✍ Robert Edelman; Kathleen Palmer; Karin G Russ; Helen P Secrest; Jo Anna L. Becke 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Phase 2a trial of 0, 1, and 3 month and

✍ Kent E. Kester; James F. Cummings; Christian F. Ockenhouse; Robin Nielsen; B. Te 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 834 KB